Pemazyre 50881-0028-01
Generic: Pemigatinib
- Manufacturer
- Incyte Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 17, 2020
- Listing Expires
- December 31, 2027
- Application
- NDA213736
Need to source Pemazyre? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pemigatinib | 13.5 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Kinase Inhibitors [MoA]
Selected Package
50881-0028-01Selected14 TABLET in 1 BOTTLE, PLASTIC (50881-028-01)